Global Next Generation Sequencing Market 2015-2019

May 14, 2015, 10:51 ET from Reportlinker

NEW YORK, May 14, 2015 /PRNewswire/ -- About NGS
Next generation sequencing (NGS) technology is used to sequence millions of small fragments of DNA simultaneously. The technology is similar to capillary electrophoresis where the bases of small fragments of DNA are sequentially identified from signals emitted, and each fragment is resynthesized from a DNA template strand. The major difference is that NGS process is extended across millions of reactions in a massively parallel fashion, rather than restricted to a single or a few DNA fragments. This technology enables rapid sequencing of large stretches of DNA base pairs spanning entire genomes with highly sophisticated instruments capable of producing hundreds of gigabytes of data in a single sequencing run. NGS finds application in whole genome, exome, and transcriptome sequencing that provide a high-resolution and global view of various applications such as the cancer genome. NGS coupled with bioinformatics tools has revolutionized cancer research, diagnosis, and therapy. This technology helps to track and trace the spread of disease and foreign contaminants in drugs.
Technavio's analysts forecast the global next generation sequencing market to grow at a CAGR of 21.36% over the period 2014-2019.

Covered in this report

This report covers the present scenario and the growth prospects of the global next generation sequencing market for the period 2015-2019. The global next generation sequencing market is divided into two segments: equipment, and reagents and consumables. To calculate the market size, the report considers the revenue generated from the sales of equipment, and reagents and consumables used in next generation sequencing in the following customer segments:
• Commercial entities such as hospitals and pharmaceutical and life sciences companies
• Research institutes
Technavio's report, Global Next Generation Sequencing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, EMEA, and APAC; it also covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the Key vendors ?operating in this market.
Key Regions
• Americas

Key vendors

• Illumina
• Roche Diagnostics
• Thermo Fischer Scientific

Other prominent vendors

• 10X Genomics
• 23andMe
• Ambry Genetics
• Axeq Technologies
• Beijing Genomics Institute
• CLC bio
• Clontech Laboratories
• Fluidigm
• Foundation Medicine
• GATC Biotech
• GeneDx
• Gnomegen
• Good Start Genetics
• Ingenuity Systems
• Knome
• NABsys
• Oxford Nanopore Technologies
• Pathogenica
• PerkinElmer
• RainDance Technologies
• Rubicon Genomics
• Sequenom
• Sigma-Aldrich
• Source Biosciences
Takara Bio
Market Driver
• Increased Adoption by New Customers
• For a full, detailed list, view our report
Market Challenge
• Technical and Implementation Issues
• For a full, detailed list, view our report
Market Trend
• Strategic Alliances
• For a full, detailed list, view our report

Key Questions Answered in this Report

• What will the market size be in 2019 and what will the growth rate be?
• What are the Key Market Trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the Key vendors ?in this market space?
• What are the market opportunities and threats faced by the Key vendors ?
• What are the strengths and weaknesses of the Key vendors ?


Research methodology is based on extensive primary and secondary research. Primary research includes in-depth interviews with industry experts, vendors, resellers and customers. Secondary research includes Technavio Platform, industry publications, company reports, news articles, analyst reports, trade associations and the data published by Government agencies.

Companies Mentioned

Illumina, Roche Diagnostics, Thermo Fischer Scientific, 10X Genomic, 23andMe, Ambry Genetics, Axeq Technologies, Beijing Genomics Institute, CLC bio, Clontech Laboratories, Fluidigm, Foundation Medicine, GATC Biotech, GeneDx, GENEWIZ, Gnomegen, Good Start Genetics, Ingenuity Systems, Knome, NABsys, Oxford Nanopore Technologies, Pathogenica, PerkinElmer, RainDance Technologies, Rubicon Genomics, Sequenom, Sigma-Aldrich, Source Biosciences, Takara Bio
Read the full report:

About Reportlinker
ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - instantly, in one place.

Contact Clare:
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker